Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Ocugen Receives FDA Ocugen Receives FDA Orphan Drug Designation for OCU300 for Treatment of oGVHD De

americanpharmaceuticalreviewAugust 10, 2017

Tag: Orphan Drug , oGVHD , OCU300

PharmaSources Customer Service